These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 7725498)

  • 1. Epstein-Barr virus lymphoblastoid cell lines from transplanted patients induce B lymphomas in SCID/hu mice: study of EBV replication.
    Blanc-Brunat N; Laurin D; Vivier G; Touraine JL; Sergeant A; Garnier JL
    Transplant Proc; 1995 Apr; 27(2):1776. PubMed ID: 7725498
    [No Abstract]   [Full Text] [Related]  

  • 2. Heterogeneity among Epstein-Barr virus-seropositive donors in the generation of immunoblastic B-cell lymphomas in SCID mice receiving human peripheral blood leukocyte grafts.
    Picchio GR; Kobayashi R; Kirven M; Baird SM; Kipps TJ; Mosier DE
    Cancer Res; 1992 May; 52(9):2468-77. PubMed ID: 1314693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
    Van Kuyk R; Mosier DE
    Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus-induced human B-cell lymphomas in SCID mice reconstituted with human peripheral blood leukocytes.
    Mosier DE; Picchio GR; Baird SM; Kobayashi R; Kipps TJ
    Cancer Res; 1992 Oct; 52(19 Suppl):5552s-5553s. PubMed ID: 1327510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-induced human B cell lymphomas in hu-PBL-SCID mice.
    Mosier DE; Picchio GR; Kirven MB; Garnier JL; Torbett BE; Baird SM; Kobayashi R; Kipps TJ
    AIDS Res Hum Retroviruses; 1992 May; 8(5):735-40. PubMed ID: 1325170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular pathological characteristics of human B-cell lymphomas induced by Epstein-Barr virus].
    Gan RL; Yin ZH; Liu TF; Dong BH; Zhou JG; Yao KT
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Oct; 35(10):925-9. PubMed ID: 14515211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation.
    Piovan E; Bonaldi L; Indraccolo S; Tosello V; Menin C; Comacchio F; Chieco-Bianchi L; Amadori A
    Leukemia; 2003 Aug; 17(8):1643-9. PubMed ID: 12886254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
    Woodford NL; Call DR; Remick DG; Rochford R
    Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Model of B immunoblastic lymphomas in the Hu-PBL-SCID mice].
    Chen DQ; Bai LJ; Liu QF; Cui LX; He W; Ba DN
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Jun; 25(3):294-6. PubMed ID: 12905742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-infected marmoset cells do not form lymphomas in mice with severe combined immunodeficiency.
    Katz BZ; Salimi B; Saini U; McNamara JG; Eisen R
    Pediatr Res; 1994 Oct; 36(4):456-60. PubMed ID: 7816520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-infected marmoset cells transfected with c-myc do not form lymphomas in mice with severe combined immunodeficiency.
    Salimi B; O'Gorman MR; Variakojis D; Bendet M; Newman M; Poupko E; Katz BZ
    Mol Genet Metab; 1998 Jul; 64(3):205-12. PubMed ID: 9719630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HHV-8/KSHV infected primary effusion lymphomas in NOD/SCID mice by azidothymidine and interferon-alpha.
    Wu W; Rochford R; Toomey L; Harrington W; Feuer G
    Leuk Res; 2005 May; 29(5):545-55. PubMed ID: 15755507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
    Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
    Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies.
    Westphal EM; Blackstock W; Feng W; Israel B; Kenney SC
    Cancer Res; 2000 Oct; 60(20):5781-8. PubMed ID: 11059774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus].
    Xia Q; Meng G; Ai Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):235-6. PubMed ID: 11717892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of hu-PBL/SCID chimeras and development of EBV-related lymphomas.
    Gan RL; Lan K; Yin ZH; Wang LJ; Song Y; Yao KT
    Chin Med Sci J; 2005 Mar; 20(1):16-22. PubMed ID: 15844306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus-Epstein-Barr virus interaction in patients with AIDS.
    Challine D; Buisson M; Cadilhac M; Germanidis G; Joab I; Eliaszewicz M; Caumes E; Flahault A; Fillet AM; Pawlotsky JM; Seigneurin JM
    J Med Virol; 2002 Aug; 67(4):510-5. PubMed ID: 12115996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
    Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.